Follow-up study for an artificial heart you may receive
Part of Heart & circulation clinical trials.
This study follows people who are planning to receive the Aeson TAH (total artificial heart) under normal care. It mainly checks outcomes after the device is placed, helping doctors monitor safety and performance over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to receive the Aeson total artificial heart under usual medical care
- You can agree to join and sign written consent approved by an ethics committee
- You are able to choose to participate on your own (not required by others)
- You are not in a “vulnerable” group that cannot freely consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
This study tests a new total artificial heart called BiVACOR for people with severe heart failure that cannot be helped by standard pumps. It is designed to keep you alive while you wait for a heart transplant.
This trial looks at how well a small heart pump (Corheart 6 LVAS) works over time for people with severe heart failure that hasn't improved with standard treatments. It aims to help those who need extra support to keep their heart pumping.
This study follows people with heart failure over time to record outcomes like illness course and death, and to understand how treatments affect results. If you have heart failure and can join regular check-ins, your information may help improve future care.
This study follows people with severe (end-stage) heart failure who are evaluated for and receive a heart transplant. It helps doctors understand what outcomes to expect after transplant, which can guide future care.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.